European Healthcare Growth

Invests in publicly listed European healthcare companies active in biotechnology, medical technology, diagnostics, and specialized services. Target companies are characterized by clear product focus, niche leadership, and advancing pipelines. The strategy emphasizes high-quality growth supported by competitive advantages, recurring revenue, and capital-efficient reinvestment.